{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:04:38Z","timestamp":1794287078338,"version":"4.9.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.vaccine.2022.10.079","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T02:43:22Z","timestamp":1667443402000},"page":"315-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system"],"prefix":"10.1016","volume":"41","author":[{"given":"Deborah E.","family":"Malden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungching","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseye A.","family":"Ogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunhea","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno J.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley K.","family":"Ackerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Jazwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Y.","family":"Tartof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.10.079_b0005","unstructured":"WHO. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. 2022 https:\/\/covid19.who.int\/ [accessed October 8 2022]."},{"issue":"12","key":"10.1016\/j.vaccine.2022.10.079_b0010","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/jamacardio.2021.3471","article-title":"Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children","volume":"6","author":"Dionne","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"50","key":"10.1016\/j.vaccine.2022.10.079_b0015","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","article-title":"The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020","volume":"69","author":"Oliver","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2022.10.079_b0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/14760584.2022.2019020","article-title":"Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccines","volume":"21","author":"Moro","year":"2022","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2022.10.079_b0025","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S2589-7500(20)30317-4","article-title":"Health data poverty: an assailable barrier to equitable digital health care","volume":"3","author":"Ibrahim","year":"2021","journal-title":"Lancet Digit Health"},{"issue":"40","key":"10.1016\/j.vaccine.2022.10.079_b0030","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1016\/j.vaccine.2021.08.055","article-title":"Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study","volume":"39","author":"Trogstad","year":"2021","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.10.079_b0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7812\/TPP\/12-031","article-title":"Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data","volume":"16","author":"Koebnick","year":"2012","journal-title":"Perm J"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.079_b0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2116298","article-title":"Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age","volume":"386","author":"Walter","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2022.10.079_b0045","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-057313","article-title":"Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years","volume":"150","author":"Hause","year":"2022","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.vaccine.2022.10.079_b0050","first-page":"e20810","article-title":"COVID-19 mRNA Vaccination, ABO Blood Type and the Severity of Self-Reported Reactogenicity in a Large Healthcare System: A Brief Report of a Cross-Sectional Study","volume":"13","author":"Allan","year":"2021","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.vaccine.2022.10.079_b0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2107456","article-title":"Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents","volume":"385","author":"Frenck","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.10.079_b0060","doi-asserted-by":"crossref","DOI":"10.4414\/SMW.2021.w30090","article-title":"Smartphone-based active vaccine safety surveillance (SmartVax) at a Swiss adult vaccination clinic - a pilot study","volume":"151","author":"Guedel","year":"2021","journal-title":"Swiss Medical Weekly"},{"issue":"9","key":"10.1016\/j.vaccine.2022.10.079_b0065","doi-asserted-by":"crossref","first-page":"347","DOI":"10.15585\/mmwr.mm7109e2","article-title":"Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5152","key":"10.1016\/j.vaccine.2022.10.079_b0070","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.15585\/mmwr.mm705152a1","article-title":"COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.vaccine.2022.10.079_b0075","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2337\/db22-0053","article-title":"Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes","volume":"71","author":"D\u2019Addio","year":"2022","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.vaccine.2022.10.079_b0080","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.079_b0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jama.2021.21625","article-title":"Why parents still hesitate to vaccinate their children against COVID-19","volume":"327","author":"Suran","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.10.079_b0090","unstructured":"Office for National Statistics. Exploring the UK's digital divide. UK Government https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/householdcharacteristics\/homeinternetandsocialmediausage\/articles\/exploringtheuksdigitaldivide\/2019-03-04 [accessed 8 October 2022]."},{"key":"10.1016\/j.vaccine.2022.10.079_b0095","doi-asserted-by":"crossref","unstructured":"Litchfield IA-O, Shukla D, Greenfield SA-O. Impact of COVID-19 on the digital divide: a rapid review. BMJ Open 2021;11(10):e053440.","DOI":"10.1136\/bmjopen-2021-053440"},{"issue":"32","key":"10.1016\/j.vaccine.2022.10.079_b0100","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1016\/j.vaccine.2021.06.054","article-title":"Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: a case control study","volume":"39","author":"Baldolli","year":"2021","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.10.079_b0105","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.vaccine.2021.11.090","article-title":"Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2\/Pfizer vaccine","volume":"40","author":"Raw","year":"2022","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2022.10.079_b0110","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2022.10.079_b0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jinf.2021.03.025","article-title":"Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers","volume":"83","author":"Tr\u00e9-Hardy","year":"2021","journal-title":"J Infect"},{"issue":"10279","key":"10.1016\/j.vaccine.2022.10.079_b0120","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(21)00501-8","article-title":"Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals","volume":"397","author":"Manisty","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2022.10.079_b0125","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.ymthe.2021.08.001","article-title":"A comprehensive analysis of the efficacy and safety of COVID-19 vaccines","volume":"29","author":"Cai","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2022.10.079_b0130","unstructured":"CDC COVID Data Tracker. 2022; Available from: https:\/\/covid.cdc.gov\/covid-data-tracker\/#vaccinations_vacc-total-admin-rate-total."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22013615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22013615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:22:14Z","timestamp":1759404134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22013615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0264410X22013615"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.079","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}